Why Catalyst Pharmaceuticals Stock Is Falling Today
In response to management announcing mixed third-quarter results and sharing tepid guidance, shares of Catalyst Pharmaceuticals (NASDAQ: CPRX), a commercial-stage biopharma focused on rare diseases, dropped 12% as of 11:03 a.m. EST on Wednesday.
Here are some headline numbers from the quarter:
Image source: Getty Images.
Source Fool.com
